Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Round Table in 100tífiques “Public Research and Research at Large Corporation”

Events
Organized by Barcelona Institut of Science & Technology and Fundació Catalana per a la recerca i…
January 21, 2021
https://gate2brain.com/wp-content/uploads/2019/01/100tifiques-2021-banner.png 600 1200 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2021-01-21 17:14:202021-05-20 10:56:27Round Table in 100tífiques “Public Research and Research at Large Corporation”
Gate2Brain

Gate2Brain co-signs its first article in ACS Publications under the title “Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma”

Publications
Alexandra Bukchin, Macarena Sanchez-Navarro, Adam Carrera, Claudia Resa-Pares, Helena Castillo-Ecija,…
January 14, 2021
https://gate2brain.com/wp-content/uploads/2021/01/News.jpg 648 1329 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2021-01-14 15:22:392021-05-20 13:19:21Gate2Brain co-signs its first article in ACS Publications under the title “Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma”
Gate2Brain

BStartup of Banco de Sabadell invests in Gate2Brain biotech

Press releases
Su tecnología tiene como objetivo transportar fármacos al cerebro aumentando la eficacia y disminuyendo…
December 29, 2020
https://gate2brain.com/wp-content/uploads/2021/02/Sabadell-Prensa.jpg 752 987 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2020-12-29 13:17:572021-03-12 11:04:05BStartup of Banco de Sabadell invests in Gate2Brain biotech
Gate2Brain

Gate2Brain seeks up to 3 million euros to reach the clinical trial

Press releases
La start up, que desarrolla una tecnología para transportar fármacos al cerebro, utilizará los fondos…
November 24, 2020
https://gate2brain.com/wp-content/uploads/2021/02/Planta-Doce.jpg 752 987 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2020-11-24 17:14:452021-03-15 07:34:23Gate2Brain seeks up to 3 million euros to reach the clinical trial
Gate2Brain

The Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups

Press releases
El programa Mind the Gap de la Fundación Botín invierte 1,5 millones de euros en tres nuevas startups…
July 9, 2020
https://gate2brain.com/wp-content/uploads/2021/02/Fundación-Botín.jpg 752 987 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2020-07-09 17:23:012021-04-07 16:25:23The Mind the Gap program of Botín Foundation invests 1.5 million euros in three new biotech startups
Gate2Brain

Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness

Press releases
Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness …
July 9, 2020
https://gate2brain.com/wp-content/uploads/2021/02/Captura-de-pantalla-2021-02-10-a-las-16.49.05.png 705 1448 Susana Meneses https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png Susana Meneses2020-07-09 15:52:532021-03-23 13:51:22Launch of Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Page 6 of 6«‹456

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del TreballThe innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.March 23, 2023 - 08:54
  • G2B at 4YFN 2023G2BGate2Brain at 4YFN-MWC23March 3, 2023 - 08:24
  • Gate2Brain at TransfiereG2BG2B at Transfiere 2023February 17, 2023 - 07:45
  • 📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022December 7, 2022 - 12:37
  • WomenStartupAwards, in the "Inspiration" category.WomeninTechSpainFinalist of Women Startup AwardsNovember 15, 2022 - 17:46

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • Barcelona to host BIO-Europe Spring 2024 March 23, 2023 biocat
  • 4YFN 2023 sees record turnout, surpassing all expectations March 6, 2023 biocat
  • European health clusters tackle sector’s main challenges in international framework February 24, 2023 biocat
  • Sector experts review main strategic challenges facing BioRegion of Catalonia February 23, 2023 biocat
  • Different health clusters in Ukraine know about the BioRegion thanks to Biocat February 23, 2023 biocat
  • Biocat and Alira Health launch market access program for BioRegion startups February 23, 2023 biocat
  • CRAASH Barcelona celebrates 5th anniversary February 23, 2023 biocat
  • Highlights: New historic record for investment in the BioRegion, new funding, more acquisitions, and ground-breaking research into strokes February 23, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}